drugset / Trial / NCT00414414

A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection

NCT00414414 ↗

RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if 30-day survival will be improved with addition of prednisone to standard tuberculosis (TB) therapy.

Timeline

Start
2007-02
Primary completion
2009-06
Completion
2009-06

Outcome

Outcome not reported

Stopped (Business): “Funding not awarded”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisone Other / unclassified — Oral